As the Food and Drug Administration (FDA) carries out a scientific review into marijuana that will inform its federal scheduling status, top officials at the agency say they are months away from releasing a regulatory assessment for hemp-based products like CBD. FDA has faced significant criticism in recent years over the lack of rules allowing … Continue reading FDA Officials Say Hemp And CBD Regulatory Plan Is Months Away As It Carries Out Marijuana Scheduling Review